By Drug Target Review2025-12-29T10:00:15
A new study published has demonstrated that reducing background brain activity can sharpen attention, identifying the Homer1 gene as key to developing new targeted treatments for ADHD and related disorders.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2024-01-26T13:22:42
Sponsored by bit.bio
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-09T09:30:19
Sponsored by Sartorius
2023-05-30T13:51:56
Sponsored by BPS Bioscience
Site powered by Webvision Cloud